Clinical Trials Logo

Filter by:
NCT ID: NCT03236779 Not yet recruiting - Plantar Fascitis Clinical Trials

A Comparative Study of Two Dry Needling Interventions for Plantar Heel Pain

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This is a clinical trial that will be done in the state of Kuwait, at the physical rehabilitation medicine hospital. the participants will be recruited from all over Kuwait, there is a clinical registry upon the ethical committee in Kuwait assigned by the ministry of health.

NCT ID: NCT03082976 Recruiting - Ovarian Cancer Clinical Trials

Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region

PREDICT
Start date: July 16, 2017
Phase: N/A
Study type: Observational

A prospective, multi-centre, epidemiological observational study designed to evaluate the prevalence of BRCA1 and BRCA2 (BReast CAncer gene) mutations in current and newly diagnosed ovarian cancer patients across different countries in the Gulf region. This study will also describe the epidemiological features for the disease for the enrolled patients.

NCT ID: NCT03066284 Recruiting - Clinical trials for Type 1 Diabetes Mellitus

A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes

Start date: March 14, 2016
Phase: N/A
Study type: Observational

Using qualitative method; a qualitative case study using semi-structured interviews to explore patients' experiences. Study population of insulin pump patients aged 11-18 years old will be recruited from pediatrics with T1D at Dasman Diabetes Institute; who started using CSII at least one year ago and their parents. Semi-structured interviews will be recorded and then transcribed word by word. Data analysis will be performed using an inductive thematic approach.

NCT ID: NCT03006198 Recruiting - Clinical trials for Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative

Tracking Biologics Along the Silk Road

HARIR
Start date: February 4, 2016
Phase: N/A
Study type: Observational

The objective of this study is to explore and describe the disease characteristics, treatment and outcomes of participants with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's Disease or ulcerative colitis as the major disease treated with REMICADE, SIMPONI or STELARA in clinical practice in the emerging regions of North Africa, the Middle East, and Western Asia.

NCT ID: NCT02941367 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

LixiRam
Start date: February 23, 2017
Phase: Phase 4
Study type: Interventional

Primary Objective: To compare the safety, in terms of percentage of patients with symptomatic documented hypoglycemia during Ramadan fast, of lixisenatide versus sulfonylurea (SU). Secondary Objectives: - To assess effect of lixisenatide versus SU on: - Changes in glycemic control; - Changes in body weight. - To assess overall safety of lixisenatide and SU.

NCT ID: NCT02805361 Active, not recruiting - Clinical trials for Type II Diabetes Mellitus

Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus

REWARD
Start date: August 21, 2016
Phase: N/A
Study type: Observational

REWARD is an Non Interventional study aims to describe the changes in the clinical outcomes of Type 2 Diabetes Mellitus patients who are treated with Dapagliflozin for a period of one year including the fasting period of Ramadan.

NCT ID: NCT02798315 Completed - Chronic Hepatitis C Clinical Trials

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

Start date: May 25, 2016
Phase: N/A
Study type: Observational

The interferon-free combination regimen of Paritaprevir/r - Ombitasvir with or without Dasabuvir (ABBVIE REGIMEN) ± Ribavirin (RBV) for the treatment of chronic hepatitis C (CHC) has been shown to be safe and effective in randomized controlled clinical trials with strict inclusion and exclusion criteria under well controlled conditions. This observational study is the first effectiveness research examining the ABBVIE REGIMEN ± RBV, used according to local label, under real world conditions in Israel in a clinical practice patient population.

NCT ID: NCT02793180 Recruiting - Heart Failure Clinical Trials

Documentation of Heart Failure in a Gulf Registry

DYSPNEA
Start date: November 2016
Phase: N/A
Study type: Observational [Patient Registry]

In the Middle East and the Gulf, the general population have high cardiovascular risks like diabetes, hypertension, smoking and obesity. The average age of a patient with an acute coronary syndrome (ACS) event is relatively young compared to Western populations. Women are multiparous and the rates of consanguinity marriages are high in this region of the world. These risk factors and conditions result in heart failure. Great deal of knowledge is missing regarding the influence of these risk factors on heart failure presentation, the causes and management of heart failure in ambulatory patients in this region of the world.

NCT ID: NCT02791867 Terminated - Clinical trials for Diabetes Mellitus, Type 2

Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake

Start date: December 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective is to determine if subjects taking the natural product AphoelineBrakeâ„¢ in addition to their standard treatment experience differences in metabolic disease control, gastrointestinal hormones and inflammatory markers diet, hunger, satiety, weight, compared to patients taking a placebo in addition to their standard treatment. The secondary objective is to study the effect of Aphoeline Brake on oxidative and inflammatory stress markers.

NCT ID: NCT02752737 Recruiting - Atrial Fibrillation Clinical Trials

Cryo AF Global Registry

Start date: May 2016
Phase: N/A
Study type: Observational [Patient Registry]

Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry